Company / Current Assets
CAPRICOR THERAPEUTICS, INC. Current Assets History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Assets
$322.9M
FY2025
5-year range
$36.4M / $322.9M
FY2021-FY2025
Trend
+97.7%
vs FY2024
Sector context
#156 of 213
Health Care
What the data says
At $323M, CAPRICOR THERAPEUTICS, INC.'s current assets ranks #156 of 213 in the Health Care sector. Current Assets has increased for 7 consecutive years, from $8M in FY2018 to $323M in FY2025.
Based on SEC 10-K filings.
$323M in FY2025 with a 5-year CAGR of +57.2%.
Improved from $51M to $323M over the past 2 years.
Health Care sector context is included.
Current Assets over time
Growth rates
- 3-Year CAGR
- +96.0%
- 5-Year CAGR
- +57.2%
- 10-Year CAGR
- -
Sector benchmark
#156 of 213 in Health CareTop 73% of 213This company $322.9M Sector average $2.5B
▼
-87.2% below sector average
Key checks
Key Insights
- CAPRICOR THERAPEUTICS, INC.'s current assets has grown for 7 consecutive years.
- 5-year CAGR of +57.2%, indicating consistent growth.
- In FY2025, current assets increased 97.7% year-over-year.
- Ranks #156 out of 213 companies in the Health Care sector.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current AssetsValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $322.9M | +97.7% |
| FY2024 | $163.4M | +221.3% |
| FY2023 | $50.9M | +18.6% |
| FY2022 | $42.9M | +17.7% |
| FY2021 | $36.4M | +8.2% |
| FY2020 | $33.7M | +219.4% |
| FY2019 | $10.5M | +24.5% |
| FY2018 | $8.5M | -46.1% |
| FY2017 | $15.7M | -13.2% |
| FY2016 | $18.1M | +29.4% |
As of FY2025 · SEC 10-K · Updated Jul 4, 2026